KA
XYL icon

Keene & Associates’s Xylem XYL Stock Holding History

Keene & Associates’s Portfolio XYL Stock Details XYL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-2,757
Closed -$305K – 82
2022
Q4 		$305K Hold
2,757
– – 0.27% 57
2022
Q3 		$241K Sell
2,757
-425
-13% -$38.6K 0.22% 69
2022
Q2 		$249K Buy
3,182
+250
+9% +$20.6K 0.23% 71
2022
Q1 		$250K Buy
2,932
+970
+49% +$92.9K 0.2% 73
2021
Q4 		$235K Buy
+1,962
New +$244K 0.2% 69

Other funds holding XYL

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Aristotle Capital Management
Aristotle Capital Management Los Angeles, California $47.7B AUM 13.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
PAMS
Pictet Asset Management (Switzerland) Geneva 73, Switzerland $84.3B AUM 26.5% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Amundi
Amundi Paris, France $416B AUM 44.19% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return

Keene & Associates's XYL Position: Q1 2023 in Review

Keene & Associates sold out of Xylem (XYL) in Q1 2023, closing a stake of 2,757 shares — an estimated $305K sold.

Keene & Associates first reported a position in XYL in Q4 2021 and held it in 5 quarters. The position peaked at $305K in Q4 2022. 839 funds tracked by Wall St. Rank hold XYL as of Q1 2023.

  • Keene & Associates reported no remaining Xylem position as of Q1 2023 after selling out during the quarter.
  • Keene & Associates sold 2,757 Xylem shares in Q1 2023, an estimated $305K.
  • Keene & Associates first reported a position in Xylem in Q4 2021 and held it in 5 quarters.
  • Keene & Associates's Xylem position peaked at $305K in Q4 2022.
  • 839 funds tracked by Wall St. Rank held Xylem as of Q1 2023.

Based on Keene & Associates's 13F filing for Q1 2023, filed 19 Apr 2023.